Artisan Partners Limited Partnership Reduces Holdings in Ascendis Pharma A/S (NASDAQ:ASND)

Artisan Partners Limited Partnership lowered its position in Ascendis Pharma A/S (NASDAQ:ASND – Free Report) by 3.6% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,995,408 shares of the biotechnology company’s stock after selling 227,043 shares during the period. […]

Related Keywords

,Ascendis Pharma ,Citigroup ,Wells Fargo Company ,Artisan Partners Limited Partnership ,Ascendis Pharmaas Company Profile ,Morgan Stanley ,Skyview Investment Advisors ,Coppell Advisory Solutions ,Exchange Commission ,Free Report ,Partners Limited Partnership ,Advisory Solutions ,View Investment Advisors ,Get Free Report ,Transcon Growth Hormone ,Transcon Parathyroid Hormone ,Transconc Type ,Ascendis Pharmaa S ,Nasdaq Asnd ,Wasnd ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,